Outcome with hyper-CVAD compared with modified hyper-CVAD
Parameter . | Hyper-CVAD . | Modified hyper-CVAD . | P . |
|---|---|---|---|
| No. treated | 22 | 11 | — |
| No. response (%) | 22 (100) | 11 (100) | NS |
| No. CR (%) | 22 (100) | 8 (73)* | .01 |
| Estimated 3-y rates (%) | |||
| Survival | 83 | 49 | .01 |
| Response duration | 77 | 62 |
Parameter . | Hyper-CVAD . | Modified hyper-CVAD . | P . |
|---|---|---|---|
| No. treated | 22 | 11 | — |
| No. response (%) | 22 (100) | 11 (100) | NS |
| No. CR (%) | 22 (100) | 8 (73)* | .01 |
| Estimated 3-y rates (%) | |||
| Survival | 83 | 49 | .01 |
| Response duration | 77 | 62 |
No significant differences in pretreatment characteristics by cohort (data not shown).—indicates not applicable; NS, not significant.
Others with partial responses.